VERA Q1 2024 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$952,000

Operating Income

-$31M

Net Income

-$28M

EPS (Diluted)

$-0.56

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$419M

Total Liabilities

$66M

Stockholders' Equity

$354M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$952,000	$506,000	+88.1%
Operating Income	-$31M	-$31M	+0.5%
Net Income	-$28M	-$30M	+5.6%